IBB vs INDA
iShares Biotechnology ETF vs iShares MSCI India ETF
IBB$196.62
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: 0.44%Yield: 0.22%
INDA$49.10
iShares MSCI India ETF
Indian large- and mid-cap equities.
Expense: 0.61%Yield: 0.00%
Quick take
- • IBB has the lower expense ratio at 0.44% vs 0.61% for INDA.
- • IBB pays a higher dividend yield (0.22%).
Side-by-side metrics
| Metric | IBB | INDA |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.61% |
Dividend yield Trailing 12-month yield. | 0.22% | 0.00% |
AUM Assets under management — bigger funds are typically more liquid. | $9.09B | $6.87B |
YTD return | 16.44% | -9.99% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.69 | 0.56 |
P/E ratio | 24.79 | 22.15 |
Last price | $196.62 | $49.10 |
Inception | — | — |
Issuer | iShares | iShares |
IBB top holdings
Top holdings · IBB
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
Sector breakdown · IBB
Healthcare100.0%
INDA top holdings
Top holdings · INDA
| HDFCBANK.NS | HDFC Bank Ltd | 6.53% |
| RELIANCE.NS | Reliance Industries Ltd | 6.09% |
| ICICIBANK.NS | ICICI Bank Ltd | 5.64% |
| BHARTIARTL.NS | Bharti Airtel Ltd | 3.87% |
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 2.74% |
| INFY.NS | Infosys Ltd | 2.42% |
| AXISBANK.BO | Axis Bank Ltd | 2.33% |
| LT.NS | Larsen & Toubro Ltd | 2.15% |
| M&M.NS | Mahindra & Mahindra Ltd | 2.08% |
| 500034 | Bajaj Finance Ltd | 1.87% |
Sector breakdown · INDA
Real Estate1.3%
Consumer Cyclical12.2%
Basic Materials8.5%
Consumer Defensive5.6%
Technology7.2%
Communication Services5.0%
Financial Services30.3%
Utilities4.2%
Industrials10.5%
Energy8.8%
Healthcare6.4%
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About INDA
INDA (iShares MSCI India ETF) is Indian large- and mid-cap equities. Managed by iShares, the fund carries $6.9B in assets under management, an expense ratio of 0.61%. Its largest holding is HDFC Bank Ltd (HDFCBANK.NS), which represents 6.5% of the portfolio. Real Estate is the fund's largest sector exposure at 1.3%.